Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22
glp 1 receptor agonist diabetes GLP-1 Services for Type 2 and Obesity Drug Development The next phase of Weight Loss Count:30
The next phase of the obesity drug race
Interestingly, Gabery et al
Weight Loss
Count:30
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
US$ 22.88
US$ 20.94
US$ 24.77
US$ 23.81
US$ 27.01
US$ 24.68
US$ 22.56
US$ 22.71
US$ 25.42
US$ 23.71
US$ 29.48
US$ 29.11
